July 31 (Reuters) - Aroa Biosurgery Ltd (ARX) :
- FY24 PRODUCT REVENUE GUIDANCE MAINTAINED AT NZ$72-75 MILLION
- FY24 PRODUCT GROSS MARGIN GUIDANCE MAINTAINED AT 85%
- FY24 NORMALISED EBITDA PROFIT GUIDANCE MAINTAINED AT NZ$1 MILLION-NZ$2 MILLION
News: ARX Aroa Biosurgery Says FY24 Product Revenue Guidance Maintained At NZ$72-75 Million
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
62.5¢ |
Change
0.015(2.46%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| 61.0¢ | 63.0¢ | 61.0¢ | $314.7K | 504.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10700 | 60.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 63.0¢ | 191221 | 5 |
View Market Depth
| Last trade - 16.10pm 12/08/2025 (20 minute delay) ? |
| ARX (ASX) Chart |